Corneal Endothelial Cell Loss
16
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support.
Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes
Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy
Corneal Endothelium in Diabetics Undergoing Phacoemulsification
Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome
Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Technique And Results In Endothelial Keratoplasty
Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco
Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density
Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy
Effect of Intravitreal Bevacizumab on Corneal Endothelium